Items Tagged with 'Markets'

ARTICLES

FDA Approves GSK's Veramyst

The FDA cleared GlaxoSmithKline's (GSK) nasal spray Veramyst April 27 for the "treatment of symptoms of seasonal and perennial rhinitis in adults and children 2 years of age and older." Read More

Roche Says Tamiflu Demand Declining

Sales of Roche's antiviral Tamiflu are on target to top the $1 billion mark this year, but the company has announced demand from government stockpiling initiatives is winding down. Read More

Roche Says Tamiflu Demand Declining

Sales of Roche's antiviral Tamiflu are on target to possibly top the $1 billion mark this year, but the company has announced demand from government stockpiling initiatives is winding down. Read More

Novartis Buys Exclusive Rights to Anti-Smoking 'Vaccine'

Novartis AG said Wednesday it will pay Cytos Biotechnology AG up to 600 million Swiss francs (US$500 million; €366 million) for the exclusive right to develop, produce and market an experimental drug it hopes will help cure smokers of their habit. Read More

Kirin's ESA Approved in Japan

Kirin Brewery has been granted Japanese manufacturing and marketing approval for its darbepoetin alfa product, a long-acting erythropoiesis-stimulating agent (ESA), under the name NESP injection. Read More